REGINA DOI: Open Payments
NPI 1427830686 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $255 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| Boston Scientific Corporation | 4 | $68 |
Products named: VRAYLAR, Ozempic, Leqembi, WaveWriter Alpha Prime 16.
Industry payments across CA — which companies pay providers there.
